Effect of mesoionic 4-phenyl-5-(cinnamoyl)-1,3,4-thiadiazolium-2- phenylamine chloride derivative salts on the activities of the nitric oxide synthase and arginase of Leishmania amazonensis

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 23, Issue 3, 2008, Pages 328-333

  Soares Bezerra, Rômulo José ^a   da Silva, Edson F ^b   Echevarria, Aurea ^b   Gomes da Silva, Liliane ^a   Cysne Finkelstein, Léa ^a   Monteiro, Fabiane Pereira ^a   Leon, Leonor L ^a   Genestra, Marcelo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Arginase; Leishmania amazonensis; Mesionic compounds; Nitric oxide; Nitric oxide synthase; Phenyl 5 (cinnamoyl) 1,3,4 thiadiazolium 2 phenylamine

Indexed keywords

1,3,4 THIADIAZOLE DERIVATIVE; 4 PHENYL 5 (CINNAMOYL) 1,3,4 THIADIAZOLIUM 2 PHENYLAMINE CHLORIDE; AMPHOLYTE; ANTILEISHMANIAL AGENT; ARGINASE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PENTAMIDINE ISETHIONATE;

AMASTIGOTE; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GENE SEQUENCE; GENETIC TRANSCRIPTION; LEISHMANIA; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; REGULATORY MECHANISM;

ANILINE COMPOUNDS; ANIMALS; ARGINASE; LEISHMANIA MEXICANA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; SALTS; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZOLES;

LEISHMANIA AMAZONENSIS; LEISHMANIA SP.;

EID: 46649105491     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360701585619     Document Type: Article

References (28)

1. Vincendeau, P., Gobert, AP, Daulouede, S., Moynet, D. and Mossalayi, MD (2003) Arginases in parasitic diseases. Trends Parasitol, 19, pp. 9-12.
2. Peluffo, G., Piacenza, L., Irigoin, F., Alvarez, MN and Radi, R. (2004) -arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol, 8, pp. 363-369.
3. Geigel, LF and Leon, LL (2003) Cyclic 3′-5′ guanosine monophosphate-dependent activity in Leishmania amazonensis. Mem Inst Oswaldo Cruz, 4, pp. 499-500.
4. Genestra, M., Cysne-Finkelstein, L. and Leon, LL (2003) Comparative analysis of nitric oxide production by Leishmania sp. Med Microbiol Immunol, 4, pp. 217-223.
5. Genestra, M., Cysne-Finkelstein, L. and Leon, LL (2003) Effect of -arginine analogs and a calcium chelator on nitric oxide (NO) production by Leishmania sp. J Enzyme Inhib Med Chem, 5, pp. 445-452.
6. Genestra, M., Souza, WJ, Guedes-Silva, D., Machado, GM, Cysne-Finkelstein, L., Bezerra, RJ, Monteiro, F. and Leon, LL (2006) Nitric oxide biosynthesis by Leishmania amazonensis promastigotes containing a high percentage of metacyclic forms. Arch Microbiol, 185:5, pp. 348-354.
7. Genestra, M., Guedes-Silva, D., Souza, WJ, Cysne-Finkelstein, L., Soares-Bezerra, RJ, Monteiro, FP and Leon, LL (2006) Nitric oxide synthase (NOS) characterization in Leishmania amazonensis axenic amastigotes. Arch Med Res, 37:3, pp. 328-333.
8. Genestra, M., Cysne-Finkelstein, L., Vignolio-Alves, L. and Leon, LL (2003) Effect of amidine derivatives on nitric oxide production by Leishmania amazonensis promastigotes and axenic amastigotes. Nitric Oxide: Biol Chem, 8, pp. 1-6.
9. Kanyo, ZF, Scolnick, LR, Ash, DE and Christianson, DW (1996) Structure of a unique binuclear manganese cluster in arginase. Nature, 383, pp. 554-557.
10. da Silva, ER, Castilho, TM, Pioker, FC, Tomich de Paula Silva, CH and Floeter-Winter, LM (2002) Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. Int J Parasitol, 32:6, pp. 727-737.
11. Soares-Bezerra, RJ, Leon, LL and Genestra, M. (2004) Recent advances on leishmaniasis chemotherapy: Intracelular molecules as a drug target. Braz J Pharm Sci, 40, pp. 139-149.
12. Senff-Ribeiro, A., Echevarria, A., Silva, EF, Veiga, S. and Oliveira, MB (2003) Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res, 5, pp. 465-471.
13. Lima, EO, Maia, RF, Filho, JMB and Filho, LX (1986) Atividades antibacteriana e antifungica de derivados mesoionicos. Rev Microbiol, 17, pp. 132-136.
14. Kier, LB and Roche, EB (1967) Medicinal chemistry of the mesoionic compounds. J Pharm Sci, 56:2, pp. 149-168.
15. Cysne-Filkelstein, L., Aguiar-Alves, F., Temporal, RM and Leon, LL (1998) Leishmania amazonensis: Long-term cultivation of axenic amastigotes is associated to metacyclogenesis of promastigotas. Exp Parasitol, 89, pp. 58-62.
16. Silva, EF, Canto-Cavalheiro, MM, Braz, VR, Cysne-Finkelstein, L., Leon, LL and Eschevarria, A. (2002) Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes. Eur J Med Chem, 12, pp. 979-984.
17. Green, LC, Wagner, DA, Glogowski, J., Skipper, Pl, Wishnok, JS and Tannenbaum, SR (1984) Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Analyt Biochem, 36, pp. 126-131.
18. Basu, NK, Kole, L., Ghosh, AI and Das, PK (1997) Isolation of a nitric oxide synthase from protozoam parasite, Leishmania donovani. FEMS Microbiol Lett, 156, pp. 43-47.
19. Hiki, K., Hattori, R., Kawai, C. and Yui, Y. (1992) Purification of insoluble nitric oxide synthase from rat cerebellum. J Biochem, 111, pp. 556-558.
20. Chen, Y. and Rosazza, JPN (1994) A bacterial nitric oxide synthase from a Nocardia species. Biochem Biophys Res Commun, 203, pp. 1251-1258.
21. Corraliza, IM, Campo, ML, Soler, G. and Modolell, MJ (1994) Determination of arginase activity in macrophages: A micromethod. Immunol Methods, 174, pp. 231-235.
22. Corraliza, IM, Soler, G., Eichmann, K. and Modolell, M. (1995) Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun, 206, pp. 667-673.
23. Schmidt, HH, Gagne, GD, Nakane, M., Pollock, JS, Miller, MF and Murad, F. (1992) Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural function for nitrinergic signal transduction. J Histochem Cytochem, 40, pp. 1439-1456.
24. Johanson, KU and Carbeg, M. (1995) NO-synthase: What can research on invertebrates add to what is already know?. Adv Neuroimmunol, 5, pp. 431-442.
25. Paveto, C., Pereira, C., Espinosa, J., Montagna, AE, Farber, M., Esteva, M., Flawia, MM and Torres, HN (1995) The nitric oxide transduction pathway in Trypanosoma cruzi. J Biol Chem, 28, pp. 16576-16579.
26. Senff-Ribeiro, A., Echevarria, A., Silva, EF, Veiga, S. and Oliveira, MB (2004) Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: A structure-activity relationship study. Anticancer Drugs, 3, pp. 269-275.
27. Kosonen, O., Kankaanranta, H., Malo-Ranta, U. and Moilanen, E. (1999) Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. Eur J Pharmacol, 2, pp. 111-117.
28. Schonafinger, K. (1999) Heterocyclic NO prodrugs. Farmaco, 54:5, pp. 316-320.